Humanin is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
The half-life of Humanin is ~30 minutes in mice; >4 hours in rats. This means dosing twice daily in animal protocols is typical to maintain stable levels. The half-life directly affects how long Humanin remains active and influences optimal injection timing.
What Is the Half-Life of Humanin?
The half-life of Humanin is ~30 minutes in mice; >4 hours in rats. This is the time it takes for blood concentration to drop by 50% after administration.
Understanding half-life is essential for designing effective dosing protocols — it determines how often you need to administer Humanin to maintain therapeutic blood levels.
What Does Humanin's Half-Life Mean for Dosing?
With a half-life of ~30 minutes in mice; >4 hours in rats, Humanin requires dosing twice daily in animal protocols to maintain stable levels. The standard dosage of 2.5 mg/kg (animal studies); human dosing not established via subcutaneous injection (proposed for humans) accounts for this pharmacokinetic profile.
After approximately 4-5 half-lives, Humanin reaches steady-state concentration — the point where the amount being absorbed equals the amount being eliminated. For Humanin, this occurs within the first few days of consistent dosing.
When Is the Best Time to Inject Humanin?
Optimal timing depends on your research goals. A half-life of ~30 minutes in mice; >4 hours in rats means peak blood levels occur shortly after injection and decline predictably.
Common timing approaches: morning injection for daytime activity, pre-bed injection for overnight effects, or split dosing (twice daily in animal protocols) for more stable levels throughout the day.
How Does Humanin's Half-Life Compare to Similar Peptides?
Humanin is a Mitochondrial-derived peptide, cytoprotective factor. Its half-life of ~30 minutes in mice; >4 hours in rats positions it with a shorter duration of action compared to some alternatives in this class.
Shorter half-lives require more frequent dosing but allow for more precise control. Longer half-lives are more convenient but carry risk of accumulation.
Calculate Your Humanin Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Humanin.
Open Calculator →Bottom Line: Humanin Half-Life and Dosing
Humanin has a half-life of ~30 minutes in mice; >4 hours in rats, supporting the standard protocol of 2.5 mg/kg (animal studies); human dosing not established dosed twice daily in animal protocols over human protocol undefined; chronic dosing in animal models.
Read our Humanin dosage guide for complete protocol details.
Complete Guide
Humanin: The Mitochondrial Peptide
Related Reading
- Humanin Dosage Guide
- Humanin Benefits
- Humanin Side Effects
- Humanin Stacking Guide
- Humanin Cycle Guide
- Humanin Research
Research-Grade Sourcing
If you're going to research Humanin, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Humanin?
Humanin (Humanin mitochondrial-derived peptide) is a Mitochondrial-derived peptide, cytoprotective factor. Endogenous 24-amino acid peptide encoded within mitochondrial DNA, released under stress conditions as a survival signal. It is researched for neuroprotection, Alzheimer's disease mitigation, cognitive preservation, anti-aging, metabolic health, mitochondrial restoration.
What is the recommended Humanin dosage?
Common dosages: 2.5 mg/kg (animal studies); human dosing not established administered twice daily in animal protocols via subcutaneous injection (proposed for humans). Cycle length: human protocol undefined; chronic dosing in animal models. Half-life: ~30 minutes in mice; >4 hours in rats. Use our peptide calculator for exact reconstitution math.
What are the side effects of Humanin?
No significant side effects in preclinical studies. Human safety data completely absent. Potential for antibody formation with chronic use.
Is Humanin safe?
Humanin has shown a preliminary safety profile in research. Not FDA-approved. Research peptide only. All research should follow appropriate safety protocols.